BorgWarner (BWA): Can This US Auto-Tech Play Keep Its 2026 Rally Alive? Turbochargers, e-Drives and a 36% YTD Rally — What Indian Investors Eyeing US Stocks Should Know By WealthChartX Desk | August 2, 2026 | US Equities · Auto-Tech · NYSE: BWA Michigan-based auto-parts supplier BorgWarner Inc. (NYSE: BWA) has quietly become one of the stronger stories in the US auto-components space this year, riding a wave of new electrification and hybrid-drivetrain contract wins. For Indian investors who route capital abroad under the RBI's Liberalised Remittance Scheme (LRS), BWA offers exposure to the global shift toward electrified and hybrid vehicles — without the single-country risk of a pure EV bet. BWA — Key Snapshot (as of Aug 1, 2026) Current Price ~US$63.74 Market Cap ~US$13.2–14.0 billion ...
Eli Lilly LLY Leader in obesity and diabetes drugs (Zepbound, Mounjaro), strong pipeline, exceptional earnings growth
Global Markets | Healthcare Equity Research Eli Lilly (NYSE: LLY): The Undisputed Leader in Obesity & Diabetes Care Zepbound, Mounjaro and a Deepening Pipeline Keep the Growth Story Intact By WealthChartX Desk | July 23, 2026 | Sector: Pharmaceuticals & Biotechnology Eli Lilly and Company (NYSE: LLY) has cemented its position as the world's most valuable pharmaceutical franchise, riding an unprecedented wave of demand for its GLP-1 based obesity and diabetes therapies. With a market capitalization that has now crossed $1.10 trillion , Lilly's combination of blockbuster drug sales, expanding margins and a deep late-stage pipeline continues to draw both institutional and retail investor attention globally — including growing interest from Indian investors accessing US markets via the RBI's Liberalised Remittance Scheme (LRS). Stock Snapshot Metric Value ...